Daniel Frigo, PhD

  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Frigo earned his Ph.D. in molecular and cellular biology from Tulane University, and then was awarded a postdoctoral fellowship and appointed to research scientist in the pharmacology and cancer biology department at Duke University Medical Center in Durham, NC. He was appointed to a faculty position at the University of Houston’s Center for Nuclear Receptors and Cell Signaling in 2010, and became an affiliate member of The Methodist Hospital Research Institute in 2012. Dr. Frigo has also been a member of the Department of Defense Prostate Cancer Research Program study sections, and served on the editorial board of Prostate Cancer and Prostatic Diseases beginning in 2012.

Research interests

Despite the discovery of nuclear receptors (NRs) more than four decades ago, their regulation and machinsims of action are still not well understood. The objective of the Frigo laboratory is to better understand how NRs function in specific disease states, with a focus on cancer. The long-term goal of Dr. Frigo’s research is to develop novel therapies that target these newly identified NR-mediated mechanisms.

Education/Academic qualification

Pharmacology and Cancer Biology, Postdoctoral Fellowship, Sarah W. Stedman Nutrition and Metabolism Center, Departments of Pharmacology and Cancer Biology and Medicine, Duke University Medical Center

Molecular & Cellular Biology, PhD, Tulane University

Free-text keywords

  • Nuclear receptors
  • Signal transduction
  • Metabolism
  • Prostate cancer
  • Autophagy


Dive into the research topics where Daniel Frigo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 6 Similar Profiles


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or